Our aims
B lymphocytes are immune cells that produce antibodies and provide long-lasting immunity. Although B cells are a major emerging therapeutic target in cancer and autoimmune rheumatological conditions, there are still substantial gaps in understanding how B cells can be harnessed to treat cardiovascular disease (CVD).
Midterm Meeting
From June 16th to June 17th 2023 members of the consortium met in Vienna to discuss the progress of the network and present the ongoing work to our reviewers.